67 results
S-1/A
EX-10.4
STOK
Stoke Therapeutics Inc
7 Jun 19
IPO registration (amended)
6:08am
to Options that are subject to different performance goals and other criteria.
(b) Date of Grant. The date of grant of an Option will be the date … to measure performance goals, if any; and (c) determine the number of Shares that may be awarded to the Participant. Performance Periods may overlap
8-K
EX-99.1
STOK
Stoke Therapeutics Inc
8 Jan 24
Regulation FD Disclosure
8:09am
thereof; our future operating results, financial position and cash runway; and our expectations, plans, aspirations and goals, including those … related to the goals of our collaboration with Acadia. Statements including words such as anticipate, plan, will, continue, expect, or ongoing
8-K
EX-99.1
STOK
Stoke Therapeutics Inc
10 Mar 22
Stoke Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
7:05am
to continue to execute on our goals for 2022.”
Fourth Quarter 2021 Business Highlights and Recent Developments
Today, the Company announced continued clinical … not be predictive of results in later stage trials, the Company’s ability to fund development activities and achieve development goals, the Company’s
8-K
EX-99.1
STOK
Stoke Therapeutics Inc
20 Sep 23
Stoke Therapeutics Appoints Ian Smith to its Board of Directors
4:37pm
to working with the team to help them achieve their goals. Together, I believe we have the opportunity to fundamentally change the way certain
8-K
STOK
Stoke Therapeutics Inc
25 Jul 23
Regulation FD Disclosure
7:05am
; the Company’s ability to fund development activities and achieve development goals; the Company’s ability to protect its intellectual property
8-K
EX-99.1
z8vc9xjsbg4ercc
28 Mar 24
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
5:20pm
8-K
18c0oban 4qzf2
3 Dec 21
Other Events
4:05pm
8-K
no8 4608za
2 Dec 22
Stoke Therapeutics Presents Data from a Combined Interim Analysis of the Phase 1/2a
9:05am
8-K
4btpn
8 Jan 24
Regulation FD Disclosure
8:09am
8-K
EX-99.1
9ugom
10 Jan 22
Entry into a Material Definitive Agreement
7:01am
8-K
EX-99.1
w3kbpuh4 3460ab
25 Mar 24
Stoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
4:03pm
8-K
87efkpq c0s
21 Sep 21
Other Events
7:06am
8-K
kcyfuig
10 Jan 22
Entry into a Material Definitive Agreement
7:01am
8-K
EX-99.2
81bc2sat8
14 Nov 22
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
7:05am
8-K
EX-99.1
6futu2 96r4
21 Sep 21
Other Events
7:06am
S-8
EX-99.1
e3kv7u7 hso9
13 Apr 23
Registration of securities for employees
4:02pm